Evaluation of Comprehensive Medication Review Completion Rates Using 3 Patient Outreach Models

Daryl E Miller1, Teresa E Roane1, Jennifer A Salo1

  • 11 Medication Therapy Management Communication and Care Center, University of Florida College of Pharmacy, Gainesville.

Abstract

Insights

Offering patients a comprehensive medication review (CMR) before direct outreach significantly increases completion rates. This strategy enhances medication therapy management (MTM) program effectiveness for health plans.

Area of Science:

  • Health Services Research
  • Pharmaceutical Services
  • Health Outcomes

Background:

  • Medication Therapy Management (MTM) programs, established by the Medicare Prescription Drug Improvement and Modernization Act of 2003, have specific enrollment criteria set by the Centers for Medicare & Medicaid Services (CMS).
  • CMS utilizes a Five-Star Quality Rating System to evaluate health plans, influencing patient enrollment and bonus payments.
  • The Comprehensive Medication Review (CMR) completion rate is a key performance measure, with various outreach models employed by health plans and vendors.

Purpose of the Study:

  • To compare the effectiveness of three distinct patient outreach models for completing Comprehensive Medication Reviews (CMRs).
  • To evaluate these models within the context of the University of Florida Medication Therapy Management Communication and Care Center (MTMCCC) across three different health plans.

Main Methods:

  • A retrospective chart analysis was conducted using data from completed CMRs at the MTMCCC.
  • The study compared CMR completion rates for three outreach models: cold calling, pre-offer acceptance by the health plan, and post-welcome letter scheduling.
  • Completion rate was calculated as the number of completed CMRs divided by the total number of beneficiaries contacted for a CMR.

Main Results:

  • The outreach model where patients were initially offered and accepted a CMR from their health plan before MTMCCC contact achieved the highest completion rate (49.8%).
  • In contrast, the other two models yielded lower completion rates of 40.5% and 23.8%.

Conclusions:

  • Proactively offering patients a Comprehensive Medication Review (CMR) and securing their acceptance before initiating MTM services can significantly improve CMR completion rates.
  • This approach may enhance the overall effectiveness of MTM programs for health plans.

Related Concept Videos

Methods of Documentation VI: Case Management Model01:15

Methods of Documentation VI: Case Management Model

The case management model is a multidisciplinary approach that involves healthcare professionals from diverse disciplines, such as physicians, nurses, therapists, social workers, and pharmacists, working collaboratively to address the various needs of patients. Each healthcare professional brings unique expertise and perspectives, contributing to a more comprehensive understanding of the patient's condition and tailoring treatment plans accordingly.
For example, a patient with a chronic...
1.0K
Pharmacovigilance01:19

Pharmacovigilance

Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
1.9K
Drug Therapy01:28

Drug Therapy

The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
376
Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions01:15

Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions

PK–PD modeling has significantly influenced FDA regulatory decisions, particularly drug approval, dosage optimization, and labeling. These models integrate pharmacokinetics (PK) and pharmacodynamics (PD) to predict drug behavior and effects, aiding in optimizing dosing regimens and enhancing the probability of clinical trial success.One notable example is Nesiritide (Natrecor®), a recombinant human brain natriuretic peptide for treating acute decompensated congestive heart failure...
60
Drug Dosing: Geriatric Patients01:15

Drug Dosing: Geriatric Patients

Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
344
Methods of Documentation II: POMR01:26

Methods of Documentation II: POMR

The Problem-Oriented Medical Record (POMR) revolutionized medical record-keeping by introducing a systematic approach focusing on the patient's problems rather than merely listing symptoms. Dr. Lawrence Weed's introduction of this method in the 1960s marked a significant advancement in medical documentation. The POMR framework consists of four key components: the database, problem list, plan of care, and progress notes.
1.6K